MSI-HIGH
Clinical trials for MSI-HIGH explained in plain language.
Never miss a new study
Get alerted when new MSI-HIGH trials appear
Sign up with your email to follow new studies for MSI-HIGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill plus immunotherapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental oral drug called Alintegimod (7HP349) combined with two immunotherapy drugs (ipilimumab and nivolumab) in people with advanced solid tumors like melanoma, lung, kidney, or liver cancer who have already tried other treatments. The goal is to see if…
Matched conditions: MSI-HIGH
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated May 26, 2026 06:56 UTC
-
New radioactive drug targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called 177Lu-RAD204, which combines a targeting antibody with a radioactive particle to seek out and attack cancer cells. The trial involves 30 adults with advanced solid tumors like lung, breast, or skin cancer that have not responded to o…
Matched conditions: MSI-HIGH
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated May 22, 2026 14:01 UTC